206 related articles for article (PubMed ID: 22701627)
1. Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.
Gordts PL; Bartelt A; Nilsson SK; Annaert W; Christoffersen C; Nielsen LB; Heeren J; Roebroek AJ
PLoS One; 2012; 7(6):e38330. PubMed ID: 22701627
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.
Gordts PL; Reekmans S; Lauwers A; Van Dongen A; Verbeek L; Roebroek AJ
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1258-64. PubMed ID: 19667105
[TBL] [Abstract][Full Text] [Related]
3. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E.
Laatsch A; Panteli M; Sornsakrin M; Hoffzimmer B; Grewal T; Heeren J
PLoS One; 2012; 7(1):e29385. PubMed ID: 22238606
[TBL] [Abstract][Full Text] [Related]
5. Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance.
Laatsch A; Merkel M; Talmud PJ; Grewal T; Beisiegel U; Heeren J
Atherosclerosis; 2009 May; 204(1):105-11. PubMed ID: 18834984
[TBL] [Abstract][Full Text] [Related]
6. Cargo-Specific Role for Retriever Subunit VPS26C in Hepatocyte Lipoprotein Receptor Recycling to Control Postprandial Triglyceride-Rich Lipoproteins.
Vos DY; Wijers M; Smit M; Huijkman N; Kloosterhuis NJ; Wolters JC; Tissink JJ; Pronk ACM; Kooijman S; Rensen PCN; Kuivenhoven JA; van de Sluis B
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):e29-e45. PubMed ID: 36353989
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism.
Moon JH; Kim HJ; Kim HM; Choi SH; Lim S; Park YJ; Jang HC; Cha BS
Thyroid; 2013 Sep; 23(9):1057-65. PubMed ID: 23517243
[TBL] [Abstract][Full Text] [Related]
9. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
[TBL] [Abstract][Full Text] [Related]
10. The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
Kim HJ; Moon JH; Kim HM; Yun MR; Jeon BH; Lee B; Kang ES; Lee HC; Cha BS
Metabolism; 2014 Jan; 63(1):112-9. PubMed ID: 24139096
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
[TBL] [Abstract][Full Text] [Related]
12. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
[TBL] [Abstract][Full Text] [Related]
13. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ
Blood; 2004 May; 103(10):3777-82. PubMed ID: 14739216
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.
Heeren J; Beisiegel U; Grewal T
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):442-8. PubMed ID: 16373604
[TBL] [Abstract][Full Text] [Related]
15. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
Gordts PL; Nock R; Son NH; Ramms B; Lew I; Gonzales JC; Thacker BE; Basu D; Lee RG; Mullick AE; Graham MJ; Goldberg IJ; Crooke RM; Witztum JL; Esko JD
J Clin Invest; 2016 Aug; 126(8):2855-66. PubMed ID: 27400128
[TBL] [Abstract][Full Text] [Related]
16. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbée JF; Havekes LM; van Vlijmen BJ; Tamsma JT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2710-5. PubMed ID: 17038633
[TBL] [Abstract][Full Text] [Related]
17. Macrophage LRP1 Promotes Diet-Induced Hepatic Inflammation and Metabolic Dysfunction by Modulating Wnt Signaling.
Au DT; Migliorini M; Strickland DK; Muratoglu SC
Mediators Inflamm; 2018; 2018():7902841. PubMed ID: 30524198
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
20. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
